Article
Population pharmacokinetics of nevirapine in Malaysian HIV patients: a non-parametric approach.
European journal of clinical pharmacology - 1 Jul 2016
Mustafa Suzana, Yusuf Wan Nazirah Wan, Woillard Jean Baptiste, Choon Tan Soo, Hassan Norul Badriah
Abstract excerpt
AIMS: Nevirapine is the first non-nucleoside reverse-transcriptase inhibitor approved and is widely used in combination therapy to treat HIV-1 infection. The pharmacokinetics of nevirapine was extensively studied in various populations with a parametric approach. Hence, this study was aimed to determine population pharmacokinetic parameters in Malaysian HIV-infected patients with a non-parametric approach which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
